A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
The integration of cytokines into stem cell and organoid research has significantly advanced drug discovery by enabling more ...
1 Laboratory of Allergology & Pulmonary Diseases, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands 2 Department of ...
Correspondence to Professor Ji-Hun Mo, Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Chungcheongnam-do, South Korea; jihunmo{at}gmail.com; Professor Hyun-Woo Shin, Pharmacology ...
P63+ airway basal progenitor cells are previously reported to have great potential to repair damaged lung epithelium. Here, we successfully cloned and expanded the autologous P63+ progenitor cells ...
Non-small cell cancer (NSCLC) tumor markers are signs of specific types of tumors. Doctors look for these markers to aid in the diagnosis and treatment of lung cancer. Doctors use several tests to ...
It feels like the Splinter Cell remake has been on its way for a while now, which isn't helped by the fact it's been over three years since we heard anything official about the game. From what we ...
Also being studied is the development of a repository of “mini-lung” cell models that can be used for lung disease research and the testing of new treatments. This would see the creation of ...
Chemotherapy for lung cancer is used for different purposes depending on the type and stage of cancer you have. This includes achieving cancer remission, shrinking a tumor before surgery, killing ...
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80 to 85% of all cases of lung cancer. There are different stages of NSCLC, ranging from 0 to 4; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results